nodes	percent_of_prediction	percent_of_DWPC	metapath
Aclidinium—Tiotropium—CYP2D6—Parkinson's disease	0.0106	0.6	CrCbGaD
Aclidinium—Trospium—CYP2D6—Parkinson's disease	0.0071	0.4	CrCbGaD
Aclidinium—CHRM4—head—Parkinson's disease	0.0058	0.0491	CbGeAlD
Aclidinium—CHRM4—nervous system—Parkinson's disease	0.0055	0.0466	CbGeAlD
Aclidinium—CHRM2—forebrain—Parkinson's disease	0.00543	0.046	CbGeAlD
Aclidinium—CHRM4—central nervous system—Parkinson's disease	0.00529	0.0449	CbGeAlD
Aclidinium—CHRM1—forebrain—Parkinson's disease	0.00495	0.0419	CbGeAlD
Aclidinium—CHRM2—cardiovascular system—Parkinson's disease	0.0046	0.0389	CbGeAlD
Aclidinium—CHRM5—head—Parkinson's disease	0.00453	0.0384	CbGeAlD
Aclidinium—CHRM3—forebrain—Parkinson's disease	0.00443	0.0375	CbGeAlD
Aclidinium—CHRM5—nervous system—Parkinson's disease	0.0043	0.0364	CbGeAlD
Aclidinium—CHRM4—brain—Parkinson's disease	0.0042	0.0356	CbGeAlD
Aclidinium—CHRM1—cardiovascular system—Parkinson's disease	0.00418	0.0354	CbGeAlD
Aclidinium—CHRM5—central nervous system—Parkinson's disease	0.00414	0.0351	CbGeAlD
Aclidinium—BCHE—brainstem—Parkinson's disease	0.00374	0.0317	CbGeAlD
Aclidinium—BCHE—forebrain—Parkinson's disease	0.00361	0.0306	CbGeAlD
Aclidinium—CHRM5—brain—Parkinson's disease	0.00329	0.0278	CbGeAlD
Aclidinium—CHRM2—head—Parkinson's disease	0.00311	0.0264	CbGeAlD
Aclidinium—BCHE—cardiovascular system—Parkinson's disease	0.00306	0.0259	CbGeAlD
Aclidinium—CHRM2—nervous system—Parkinson's disease	0.00295	0.025	CbGeAlD
Aclidinium—CHRM2—central nervous system—Parkinson's disease	0.00284	0.0241	CbGeAlD
Aclidinium—CHRM1—head—Parkinson's disease	0.00283	0.024	CbGeAlD
Aclidinium—CHRM1—nervous system—Parkinson's disease	0.00269	0.0228	CbGeAlD
Aclidinium—BCHE—medulla oblongata—Parkinson's disease	0.00261	0.0221	CbGeAlD
Aclidinium—CHRM1—central nervous system—Parkinson's disease	0.00259	0.0219	CbGeAlD
Aclidinium—CHRM3—head—Parkinson's disease	0.00253	0.0215	CbGeAlD
Aclidinium—CHRM3—nervous system—Parkinson's disease	0.0024	0.0204	CbGeAlD
Aclidinium—BCHE—midbrain—Parkinson's disease	0.00239	0.0202	CbGeAlD
Aclidinium—BCHE—spinal cord—Parkinson's disease	0.00233	0.0197	CbGeAlD
Aclidinium—CHRM3—central nervous system—Parkinson's disease	0.00231	0.0196	CbGeAlD
Aclidinium—CHRM2—brain—Parkinson's disease	0.00226	0.0191	CbGeAlD
Aclidinium—BCHE—head—Parkinson's disease	0.00207	0.0175	CbGeAlD
Aclidinium—CHRM1—brain—Parkinson's disease	0.00205	0.0174	CbGeAlD
Aclidinium—BCHE—nervous system—Parkinson's disease	0.00196	0.0166	CbGeAlD
Aclidinium—BCHE—central nervous system—Parkinson's disease	0.00189	0.016	CbGeAlD
Aclidinium—BCHE—cerebellum—Parkinson's disease	0.00185	0.0156	CbGeAlD
Aclidinium—CHRM3—brain—Parkinson's disease	0.00184	0.0156	CbGeAlD
Aclidinium—BCHE—brain—Parkinson's disease	0.0015	0.0127	CbGeAlD
Aclidinium—CHRM4—Signaling Pathways—GRM5—Parkinson's disease	0.00036	0.000417	CbGpPWpGaD
Aclidinium—CHRM1—Circadian rythm related genes—MAPK8—Parkinson's disease	0.000356	0.000412	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—RIT2—Parkinson's disease	0.000354	0.00041	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—RIT2—Parkinson's disease	0.000353	0.000409	CbGpPWpGaD
Aclidinium—CHRM1—GPCR ligand binding—HTR2A—Parkinson's disease	0.00035	0.000405	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—RIT2—Parkinson's disease	0.00035	0.000405	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—ADORA2A—Parkinson's disease	0.00035	0.000404	CbGpPWpGaD
Aclidinium—CHRM3—GPCR ligand binding—HTR2A—Parkinson's disease	0.000349	0.000404	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—GFAP—Parkinson's disease	0.000349	0.000404	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—ADORA2A—Parkinson's disease	0.000348	0.000403	CbGpPWpGaD
Aclidinium—CHRM2—GPCR ligand binding—HTR2A—Parkinson's disease	0.000346	0.0004	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—ADORA2A—Parkinson's disease	0.000345	0.000399	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—GRM5—Parkinson's disease	0.000345	0.000399	CbGpPWpGaD
Aclidinium—BCHE—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	0.000344	0.000397	CbGpPWpGaD
Aclidinium—CHRM2—SIDS Susceptibility Pathways—TNF—Parkinson's disease	0.000341	0.000394	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—GRK5—Parkinson's disease	0.000336	0.000389	CbGpPWpGaD
Aclidinium—CHRM4—GPCR downstream signaling—EDN1—Parkinson's disease	0.000335	0.000388	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—GRK5—Parkinson's disease	0.000335	0.000387	CbGpPWpGaD
Aclidinium—CHRM1—GPCR downstream signaling—HTR1A—Parkinson's disease	0.000334	0.000386	CbGpPWpGaD
Aclidinium—CHRM3—GPCR downstream signaling—HTR1A—Parkinson's disease	0.000333	0.000385	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—GRK5—Parkinson's disease	0.000332	0.000384	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—DDC—Parkinson's disease	0.00033	0.000382	CbGpPWpGaD
Aclidinium—CHRM2—GPCR downstream signaling—HTR1A—Parkinson's disease	0.00033	0.000381	CbGpPWpGaD
Aclidinium—CHRM1—GPCR downstream signaling—TAC1—Parkinson's disease	0.000329	0.000381	CbGpPWpGaD
Aclidinium—CHRM3—GPCR downstream signaling—TAC1—Parkinson's disease	0.000328	0.000379	CbGpPWpGaD
Aclidinium—CHRM2—GPCR downstream signaling—TAC1—Parkinson's disease	0.000325	0.000376	CbGpPWpGaD
Aclidinium—CHRM1—GPCR downstream signaling—DRD1—Parkinson's disease	0.000323	0.000373	CbGpPWpGaD
Aclidinium—CHRM3—GPCR downstream signaling—DRD1—Parkinson's disease	0.000322	0.000372	CbGpPWpGaD
Aclidinium—CHRM5—GPCR downstream signaling—EDN1—Parkinson's disease	0.000321	0.000372	CbGpPWpGaD
Aclidinium—CHRM2—GPCR downstream signaling—DRD1—Parkinson's disease	0.000318	0.000368	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—FGF20—Parkinson's disease	0.000316	0.000365	CbGpPWpGaD
Aclidinium—CHRM1—GPCR downstream signaling—DRD3—Parkinson's disease	0.000312	0.000361	CbGpPWpGaD
Aclidinium—CHRM3—GPCR downstream signaling—DRD3—Parkinson's disease	0.000311	0.00036	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—GSTA4—Parkinson's disease	0.000311	0.00036	CbGpPWpGaD
Aclidinium—CHRM2—GPCR downstream signaling—DRD3—Parkinson's disease	0.000308	0.000357	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—ADORA2A—Parkinson's disease	0.000306	0.000354	CbGpPWpGaD
Aclidinium—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	0.000306	0.000354	CbGpPWpGaD
Aclidinium—CHRM4—Signaling by GPCR—EDN1—Parkinson's disease	0.000305	0.000352	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—HTR1A—Parkinson's disease	0.000303	0.000351	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—FGF20—Parkinson's disease	0.000302	0.00035	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—HTR1A—Parkinson's disease	0.000302	0.00035	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—GRM4—Parkinson's disease	0.000301	0.000349	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—GRM4—Parkinson's disease	0.0003	0.000347	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—HTR1A—Parkinson's disease	0.000299	0.000346	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—TAC1—Parkinson's disease	0.000299	0.000346	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—TAC1—Parkinson's disease	0.000298	0.000345	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—GRM4—Parkinson's disease	0.000297	0.000344	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—TAC1—Parkinson's disease	0.000295	0.000341	CbGpPWpGaD
Aclidinium—CHRM4—GPCR downstream signaling—HTR2A—Parkinson's disease	0.000293	0.00034	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—ADORA2A—Parkinson's disease	0.000293	0.000339	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—DRD1—Parkinson's disease	0.000293	0.000339	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—DRD1—Parkinson's disease	0.000292	0.000338	CbGpPWpGaD
Aclidinium—CHRM5—Signaling by GPCR—EDN1—Parkinson's disease	0.000292	0.000338	CbGpPWpGaD
Aclidinium—CHRM1—GPCR downstream signaling—ADRBK1—Parkinson's disease	0.000292	0.000338	CbGpPWpGaD
Aclidinium—CHRM3—GPCR downstream signaling—ADRBK1—Parkinson's disease	0.000291	0.000336	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—DRD1—Parkinson's disease	0.000289	0.000335	CbGpPWpGaD
Aclidinium—CHRM2—GPCR downstream signaling—ADRBK1—Parkinson's disease	0.000288	0.000333	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—PENK—Parkinson's disease	0.000286	0.00033	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—MAG—Parkinson's disease	0.000286	0.00033	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—MAG—Parkinson's disease	0.000285	0.000329	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—PENK—Parkinson's disease	0.000285	0.000329	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—DRD3—Parkinson's disease	0.000284	0.000328	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—DRD3—Parkinson's disease	0.000283	0.000327	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—INSR—Parkinson's disease	0.000283	0.000327	CbGpPWpGaD
Aclidinium—CHRM1—GPCR downstream signaling—HTR7—Parkinson's disease	0.000283	0.000327	CbGpPWpGaD
Aclidinium—CHRM1—GPCR downstream signaling—DRD2—Parkinson's disease	0.000283	0.000327	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—MAG—Parkinson's disease	0.000282	0.000326	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—PENK—Parkinson's disease	0.000282	0.000326	CbGpPWpGaD
Aclidinium—CHRM3—GPCR downstream signaling—HTR7—Parkinson's disease	0.000282	0.000326	CbGpPWpGaD
Aclidinium—CHRM3—GPCR downstream signaling—DRD2—Parkinson's disease	0.000282	0.000326	CbGpPWpGaD
Aclidinium—CHRM5—GPCR downstream signaling—HTR2A—Parkinson's disease	0.000281	0.000325	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—PLA2G6—Parkinson's disease	0.00028	0.000324	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—DRD3—Parkinson's disease	0.00028	0.000324	CbGpPWpGaD
Aclidinium—CHRM2—GPCR downstream signaling—HTR7—Parkinson's disease	0.000279	0.000323	CbGpPWpGaD
Aclidinium—CHRM2—GPCR downstream signaling—DRD2—Parkinson's disease	0.000279	0.000323	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—MAOB—Parkinson's disease	0.000278	0.000321	CbGpPWpGaD
Aclidinium—CHRM2—SIDS Susceptibility Pathways—IL6—Parkinson's disease	0.000275	0.000318	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—INSR—Parkinson's disease	0.000271	0.000313	CbGpPWpGaD
Aclidinium—BCHE—Metabolism—CYP2D6—Parkinson's disease	0.000268	0.00031	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—FGB—Parkinson's disease	0.000267	0.000309	CbGpPWpGaD
Aclidinium—CHRM4—Signaling by GPCR—HTR2A—Parkinson's disease	0.000266	0.000308	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—HTR1A—Parkinson's disease	0.000266	0.000307	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—ADRBK1—Parkinson's disease	0.000265	0.000307	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—ADRBK1—Parkinson's disease	0.000264	0.000306	CbGpPWpGaD
Aclidinium—BCHE—Metabolism—CTGF—Parkinson's disease	0.000263	0.000305	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—TAC1—Parkinson's disease	0.000262	0.000303	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—ADRBK1—Parkinson's disease	0.000261	0.000303	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—PDYN—Parkinson's disease	0.000261	0.000302	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—PDYN—Parkinson's disease	0.00026	0.000301	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—PDYN—Parkinson's disease	0.000258	0.000298	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—DRD1—Parkinson's disease	0.000257	0.000297	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—DRD2—Parkinson's disease	0.000257	0.000297	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—HTR7—Parkinson's disease	0.000257	0.000297	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—FGB—Parkinson's disease	0.000256	0.000296	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—DRD2—Parkinson's disease	0.000256	0.000296	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—HTR7—Parkinson's disease	0.000256	0.000296	CbGpPWpGaD
Aclidinium—CHRM5—Signaling by GPCR—HTR2A—Parkinson's disease	0.000255	0.000295	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—HTR1A—Parkinson's disease	0.000254	0.000294	CbGpPWpGaD
Aclidinium—BCHE—Metabolism of proteins—INS—Parkinson's disease	0.000254	0.000293	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—HTR7—Parkinson's disease	0.000253	0.000293	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—DRD2—Parkinson's disease	0.000253	0.000293	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—TAC1—Parkinson's disease	0.000251	0.00029	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—DRD3—Parkinson's disease	0.000249	0.000288	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—DRD1—Parkinson's disease	0.000246	0.000284	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—GFAP—Parkinson's disease	0.000246	0.000284	CbGpPWpGaD
Aclidinium—BCHE—Metabolism—CYP2E1—Parkinson's disease	0.000245	0.000284	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—GFAP—Parkinson's disease	0.000245	0.000283	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—GRM5—Parkinson's disease	0.000243	0.000281	CbGpPWpGaD
Aclidinium—BCHE—Metabolism—NQO1—Parkinson's disease	0.000243	0.000281	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—GFAP—Parkinson's disease	0.000242	0.000281	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—GRM5—Parkinson's disease	0.000242	0.00028	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—GRM5—Parkinson's disease	0.00024	0.000277	CbGpPWpGaD
Aclidinium—BCHE—Metabolism—TH—Parkinson's disease	0.000239	0.000277	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—DRD3—Parkinson's disease	0.000238	0.000275	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—ADRBK1—Parkinson's disease	0.000232	0.000269	CbGpPWpGaD
Aclidinium—BCHE—Metabolism—CYCS—Parkinson's disease	0.00023	0.000266	CbGpPWpGaD
Aclidinium—CHRM1—Circadian rythm related genes—IL6—Parkinson's disease	0.000227	0.000263	CbGpPWpGaD
Aclidinium—CHRM1—GPCR downstream signaling—EDN1—Parkinson's disease	0.000226	0.000262	CbGpPWpGaD
Aclidinium—CHRM3—GPCR downstream signaling—EDN1—Parkinson's disease	0.000225	0.000261	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—DRD2—Parkinson's disease	0.000225	0.00026	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—HTR7—Parkinson's disease	0.000225	0.00026	CbGpPWpGaD
Aclidinium—CHRM2—GPCR downstream signaling—EDN1—Parkinson's disease	0.000223	0.000258	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—ADRBK1—Parkinson's disease	0.000222	0.000257	CbGpPWpGaD
Aclidinium—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	0.000215	0.000249	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—DRD2—Parkinson's disease	0.000215	0.000249	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—HTR7—Parkinson's disease	0.000215	0.000249	CbGpPWpGaD
Aclidinium—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	0.000215	0.000249	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—FGF20—Parkinson's disease	0.000213	0.000246	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—FGF20—Parkinson's disease	0.000212	0.000246	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—FGF20—Parkinson's disease	0.00021	0.000243	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—ADORA2A—Parkinson's disease	0.000206	0.000239	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—CYP2D6—Parkinson's disease	0.000206	0.000239	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—ADORA2A—Parkinson's disease	0.000206	0.000238	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—EDN1—Parkinson's disease	0.000205	0.000238	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—EDN1—Parkinson's disease	0.000205	0.000237	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—ADORA2A—Parkinson's disease	0.000204	0.000236	CbGpPWpGaD
Aclidinium—BCHE—Metabolism—COMT—Parkinson's disease	0.000203	0.000235	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—EDN1—Parkinson's disease	0.000203	0.000235	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—CTGF—Parkinson's disease	0.000202	0.000234	CbGpPWpGaD
Aclidinium—BCHE—Metabolism—GSTP1—Parkinson's disease	0.000202	0.000234	CbGpPWpGaD
Aclidinium—BCHE—Metabolism—MAOA—Parkinson's disease	0.000202	0.000234	CbGpPWpGaD
Aclidinium—BCHE—Metabolism—HMOX1—Parkinson's disease	0.0002	0.000231	CbGpPWpGaD
Aclidinium—CHRM1—GPCR downstream signaling—HTR2A—Parkinson's disease	0.000198	0.000229	CbGpPWpGaD
Aclidinium—CHRM3—GPCR downstream signaling—HTR2A—Parkinson's disease	0.000197	0.000228	CbGpPWpGaD
Aclidinium—CHRM2—GPCR downstream signaling—HTR2A—Parkinson's disease	0.000195	0.000226	CbGpPWpGaD
Aclidinium—BCHE—Metabolism—ABCB1—Parkinson's disease	0.000192	0.000222	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—INSR—Parkinson's disease	0.000191	0.00022	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—INSR—Parkinson's disease	0.00019	0.00022	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—CYP2E1—Parkinson's disease	0.000189	0.000218	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—IGF2—Parkinson's disease	0.000188	0.000218	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—INSR—Parkinson's disease	0.000188	0.000218	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—NQO1—Parkinson's disease	0.000187	0.000216	CbGpPWpGaD
Aclidinium—BCHE—Metabolism—GSTM1—Parkinson's disease	0.000186	0.000215	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—TH—Parkinson's disease	0.000184	0.000213	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—IGF1R—Parkinson's disease	0.000182	0.000211	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—IGF2—Parkinson's disease	0.00018	0.000209	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—FGB—Parkinson's disease	0.00018	0.000208	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—EDN1—Parkinson's disease	0.00018	0.000208	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—HTR2A—Parkinson's disease	0.00018	0.000208	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—FGB—Parkinson's disease	0.00018	0.000208	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—HTR1A—Parkinson's disease	0.000179	0.000207	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—HTR2A—Parkinson's disease	0.000179	0.000207	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—HTR1A—Parkinson's disease	0.000179	0.000207	CbGpPWpGaD
Aclidinium—BCHE—Metabolism—GPX1—Parkinson's disease	0.000178	0.000206	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—FGB—Parkinson's disease	0.000178	0.000206	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—HTR2A—Parkinson's disease	0.000177	0.000205	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—HTR1A—Parkinson's disease	0.000177	0.000205	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—CYCS—Parkinson's disease	0.000177	0.000204	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—TAC1—Parkinson's disease	0.000176	0.000204	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—TAC1—Parkinson's disease	0.000176	0.000204	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—IGF1R—Parkinson's disease	0.000174	0.000202	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—TAC1—Parkinson's disease	0.000174	0.000202	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—DRD1—Parkinson's disease	0.000173	0.0002	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—DRD1—Parkinson's disease	0.000172	0.0002	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—EDN1—Parkinson's disease	0.000172	0.000199	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—DRD1—Parkinson's disease	0.000171	0.000198	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—DRD3—Parkinson's disease	0.000168	0.000194	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—DRD3—Parkinson's disease	0.000167	0.000193	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—DRD3—Parkinson's disease	0.000165	0.000191	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—NGF—Parkinson's disease	0.000165	0.000191	CbGpPWpGaD
Aclidinium—BCHE—Metabolism—MTHFR—Parkinson's disease	0.000164	0.00019	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—NGF—Parkinson's disease	0.000158	0.000183	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—HTR2A—Parkinson's disease	0.000157	0.000182	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—ADRBK1—Parkinson's disease	0.000156	0.000181	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—COMT—Parkinson's disease	0.000156	0.000181	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—ADRBK1—Parkinson's disease	0.000156	0.00018	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—GSTP1—Parkinson's disease	0.000156	0.00018	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—MAOA—Parkinson's disease	0.000155	0.00018	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—ADRBK1—Parkinson's disease	0.000154	0.000179	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—HMOX1—Parkinson's disease	0.000153	0.000178	CbGpPWpGaD
Aclidinium—BCHE—Metabolism—APOE—Parkinson's disease	0.000153	0.000177	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—HTR7—Parkinson's disease	0.000152	0.000175	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—DRD2—Parkinson's disease	0.000152	0.000175	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—DRD2—Parkinson's disease	0.000151	0.000175	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—HTR7—Parkinson's disease	0.000151	0.000175	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—HTR2A—Parkinson's disease	0.000151	0.000174	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—HTR7—Parkinson's disease	0.00015	0.000173	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—DRD2—Parkinson's disease	0.00015	0.000173	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—ABCB1—Parkinson's disease	0.000147	0.00017	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—APOE—Parkinson's disease	0.000146	0.000169	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—GSTM1—Parkinson's disease	0.000143	0.000165	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—APOE—Parkinson's disease	0.00014	0.000162	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—GPX1—Parkinson's disease	0.000137	0.000158	CbGpPWpGaD
Aclidinium—BCHE—Metabolism—INS—Parkinson's disease	0.000131	0.000151	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—IGF2—Parkinson's disease	0.000127	0.000147	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—IGF2—Parkinson's disease	0.000127	0.000146	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—MTHFR—Parkinson's disease	0.000126	0.000146	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—IGF2—Parkinson's disease	0.000125	0.000145	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—INS—Parkinson's disease	0.000125	0.000145	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—IGF1R—Parkinson's disease	0.000123	0.000142	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—IGF1R—Parkinson's disease	0.000122	0.000142	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—EDN1—Parkinson's disease	0.000121	0.00014	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—IGF1R—Parkinson's disease	0.000121	0.00014	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—EDN1—Parkinson's disease	0.000121	0.00014	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—EDN1—Parkinson's disease	0.00012	0.000139	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—INS—Parkinson's disease	0.00012	0.000139	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—APOE—Parkinson's disease	0.000118	0.000136	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—NGF—Parkinson's disease	0.000112	0.000129	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—NGF—Parkinson's disease	0.000111	0.000129	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—NGF—Parkinson's disease	0.00011	0.000127	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—HTR2A—Parkinson's disease	0.000106	0.000123	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—HTR2A—Parkinson's disease	0.000106	0.000122	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—HTR2A—Parkinson's disease	0.000105	0.000121	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—INS—Parkinson's disease	0.0001	0.000116	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—APOE—Parkinson's disease	9.87e-05	0.000114	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—APOE—Parkinson's disease	9.84e-05	0.000114	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—APOE—Parkinson's disease	9.74e-05	0.000113	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—CASP3—Parkinson's disease	9.31e-05	0.000108	CbGpPWpGaD
Aclidinium—CHRM4—Signaling by GPCR—IL6—Parkinson's disease	9.25e-05	0.000107	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—CASP3—Parkinson's disease	8.91e-05	0.000103	CbGpPWpGaD
Aclidinium—CHRM5—Signaling by GPCR—IL6—Parkinson's disease	8.86e-05	0.000102	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—MAPK8—Parkinson's disease	8.56e-05	9.9e-05	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—INS—Parkinson's disease	8.43e-05	9.75e-05	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—INS—Parkinson's disease	8.4e-05	9.72e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—INS—Parkinson's disease	8.32e-05	9.63e-05	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—MAPK8—Parkinson's disease	8.19e-05	9.48e-05	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—CASP3—Parkinson's disease	6.28e-05	7.26e-05	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—CASP3—Parkinson's disease	6.26e-05	7.24e-05	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—IL6—Parkinson's disease	6.24e-05	7.22e-05	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—IL6—Parkinson's disease	6.22e-05	7.19e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—CASP3—Parkinson's disease	6.2e-05	7.17e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—IL6—Parkinson's disease	6.16e-05	7.12e-05	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—MAPK8—Parkinson's disease	5.77e-05	6.67e-05	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—MAPK8—Parkinson's disease	5.75e-05	6.65e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—MAPK8—Parkinson's disease	5.69e-05	6.59e-05	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—IL6—Parkinson's disease	5.46e-05	6.32e-05	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—IL6—Parkinson's disease	5.23e-05	6.05e-05	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—IL6—Parkinson's disease	3.68e-05	4.26e-05	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—IL6—Parkinson's disease	3.67e-05	4.25e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—IL6—Parkinson's disease	3.64e-05	4.21e-05	CbGpPWpGaD
